Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines

ABSTRACT COVID-19 infection is a global health issue, and vaccination is the main strategy to control this pandemic. In this study, 189 participants received BNT162b2 or CoronaVac vaccine, and 133 of them recorded adverse events (AEs) daily for 4 weeks after vaccination. Their neutralizing antibody...

Полное описание

Библиографические подробности

Главные авторы:	Ruiqi Zhang, Ka-Yi Leung, Danlei Liu, Yujing Fan, Lu Lu, Pui-Chun Chan, Kelvin Kai-Wang To, Honglin Chen, Kwok-Yung Yuen, Kwok-Hung Chan, Ivan Fan-Ngai Hung
Формат:	Artigo
Язык:	Inglês
Опубликовано:	American Society for Microbiology 2022-04-01
Серии:	mSphere
Предметы:	BNT162b2 COVID-19 CoronaVac neutralizing antibodies side effects vaccination
Online-ссылка:	https://journals.asm.org/doi/10.1128/msphere.00915-21
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!